Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Rule 425 Communication · 425

Medtronic plc

MDTNYSEEQUITYCurrent

Rule 425 Communication

Filed Sep 22, 2026Accepted Sep 22, 2026, 4:52 PM EDTCIK 1613103Accession 0001628280-26-063063
Share

Company context

Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission - to alleviate pain, restore health, and extend life - unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us

Current securities

Recent company filings

  1. 425 filingSep 23, 2026
  2. 425 filingSep 21, 2026
  3. 425 filingSep 18, 2026
  4. 425 filingSep 17, 2026
  5. SC TO-I/A filingSep 17, 2026

As-filed source

Primary evidence